Developer docs
API playgroundTry for free, no card

Search company profiles

Citolab

Full company profile

uuid002odsq

Namestring
Citolab
Legal namestring
Citolab Laboratório de Citologia Clínica e Histopatologia Ltda
Websiteurl
citolab.com.br
Company typeenum
Private
Founded yearint
1989
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersCuritiba, Brazil
HQ citystring
Curitiba
HQ countrystring
Brazil
HQ regionstring
Latin America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical pathology services, cytology diagnostics, histopathology testing, immunohistochemistry services, molecular diagnostics
Industry2 codes
PRIMARYHLAFAMAE
Molecular Diagnostics & Genomics Laboratories
SECONDARYHLAGAEAB
Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
NAICS code1 code
  • Medical Laboratories621511
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Clinical Pathology Laboratory Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Clinical pathology services
TypeSubscription Recurring
Description

Laboratory diagnostic services including cytology, histopathology, immunohistochemistry, and molecular testing for medical clinics, hospitals, and healthcare providers. Services are billed through health insurance plans (convênios) or direct patient payment.

citolab.com.br
2Specialized diagnostic testing
TypeOne Time License
Description

Advanced genetic testing services including NIPT, hereditary cancer panels, nutrigenetic tests (NutriGen), sports genetics (GymGen, FitGen), dermatogenetic testing (AgeGen), and sex determination testing

citolab.com.br
3Healthcare insurance (Convênios)
TypeSubscription Recurring
Description

Partnership with health insurance providers for covered diagnostic services

citolab.com.br
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Citolab is a clinical cytology and histopathology laboratory providing anatomical pathology, biopsy and surgical specimen analysis, cytology (conventional and liquid-based SurePath), automated immunohistochemistry with 48-72 hour turnaround, molecular diagnostics including NGS hereditary cancer panels, HPV genotyping, and specialized pathology services. The lab also offers genetic testing (nutrigenetics, sports genetics, dermatogenetics), prenatal testing (NIPT, fetal sexing), infectious disease panels, and COVID-19 antigen testing for healthcare providers and patients in the Curitiba metropolitan region.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Immunohistochemistry turnaround time of 48-72 hours
+3 more records
Product overview1 text field

Citolab is a clinical cytology and histopathology laboratory offering comprehensive anatomical pathology and diagnostic testing services. The core portfolio centers on anatomical pathology services including surgical specimen analysis, biopsies, cytology (conventional and liquid-based), and intraoperative frozen section examinations. The laboratory provides specialized immunohistochemistry with automated 48-72 hour turnaround and molecular diagnostics including NGS hereditary cancer panels (26 genes), HPV genotyping, and KRAS/NRAS/BRAF testing. Citolab also offers genetic testing services (NutriGen, GymGen, FitGen, AgeGen) for nutrigenetics, athletic performance, fitness optimization, and dermatogenetics. Prenatal testing includes NIPT and fetal sexing via PCR. The service portfolio spans oncology diagnostics, infectious disease testing (STI panels, COVID-19), neuropathology, dermatopathology, and mastopathology, complemented by 24-hour logistics support and digital result delivery. The laboratory operates multiple collection sites in Curitiba and São José dos Pinhais with priority service for transplant patients.

Product and service20 records
1Anatomical Pathology / Biopsies / Surgical Specimens
Categorycore product
2Cytopathology (Liquid-Based and Conventional)
Categorycore product
3Immunohistochemistry / Immunocytochemistry
Categorycore product
4Molecular Diagnostics (NGS Hereditary Cancer Panel)
Categorycore product
5HPV Testing and Genotyping
Categorycore product
6NIPT - Non-Invasive Prenatal Test
Categorycore product
7Neuropathology Services
Categoryspecialty service
8Dermatopathology Services
Categoryspecialty service
9Mastopathology Services
Categoryspecialty service
10NutriGen - Nutrigenetic Test
Categoryspecialty test
11GymGen / FitGen - Genetic Sports and Fitness Tests
Categoryspecialty test
12AgeGen - Dermatogenetic Test
Categoryspecialty test
13STI/IST Molecular Panel
Categorycore product
14KRAS/NRAS/BRAF Molecular Studies
Categorycore product
15Microsatellite Instability (MSI) Testing
Categorycore product
16COVID-19 Antigen Rapid Test
Categoryspecialty test
17Per-Operative Frozen Section Examination
Categorycore product
18Fine Needle Aspiration Biopsy (FNAB)
Categorycore product
19Second Opinion / Slide Review
Categorycore product
2024-Hour Logistics Assistance
Categorysupport service
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeOthers
Description

US-based molecular diagnostics company commercialising Oncotype DX and other genomic oncology tests globally. Not a direct competitor but provides comparable molecular/genomic oncology testing that Brazilian specialty labs like Citolab compete against in hereditary cancer and tumor profiling cases.

TypeDirect peer
Description

Brazilian diagnostic medicine chain offering clinical analysis, imaging, and specialty testing through a network of patient service centers across multiple states. Closest direct comparable in business model to Citolab: anatomical pathology, molecular diagnostics, convênio partnerships, and physician-referred testing in a Brazilian regional hub context.

TypeBroad incumbent
Description

US clinical laboratory incumbent offering anatomical pathology, molecular diagnostics, and genetic testing at nationwide scale through physician and hospital channels. Comparable to Citolab in test categories and physician-referred anatomical pathology, but vastly larger and operating in a different regulatory and reimbursement environment.

TypeBroad incumbent
Description

Largest Brazilian integrated diagnostics company operating brands such as Delboni Auriemo, Sérgio Franco, and Pasteur across clinical analysis, imaging, and hospital diagnostics. Operates in the same anatomical pathology, molecular, and convênio-driven market as Citolab but at national scale across hundreds of units and integrated hospital systems.

TypeDirect peer
Description

Large Brazilian clinical laboratory with a strong specialty and molecular diagnostics portfolio, including genetic testing and hospital partnerships. Highly comparable to Citolab in test menu breadth (oncology IHC, molecular, genetics) and target customer base (hospitals, clinicians, convênios), though at materially larger national scale.

6Hospital Israelita Albert Einstein
TypeOthers
Description

Brazilian tertiary hospital system operating an integrated clinical laboratory and reference diagnostic service for complex and esoteric testing. Adjacent rather than directly competing with Citolab, but engages the same specialist pathologists and serves overlapping subspecialty referral cases from across Brazil.

TypeBroad incumbent
Description

US specialty oncology testing company focused on molecular and anatomic pathology for hospitals, oncologists, and clinical trials. Highly comparable to Citolab in subspecialty oncology and molecular focus, though operating at multi-state US scale rather than regional Brazilian scale.

TypeBroad incumbent
Description

Major Brazilian diagnostics company offering clinical analysis, imaging, and specialty testing with a strong reference-lab positioning in oncology and genetics. Comparable to Citolab in subspecialty test offerings and physician-referral channel, but with a São Paulo-centric premium positioning and far larger operating scale.

TypeDirect peer
Description

Brazilian clinical diagnostics chain with regional presence focused on routine and specialty testing for physicians, hospitals, and convênios. Comparable to Citolab in business model (clinical analysis, convênio billing, physician referrals) and regional hub footprint in Brazil.

TypeEmerging player
Description

US-based cell-free DNA testing company with leading NIPT, hereditary cancer, and oncology monitoring products. Direct comparable to Citolab's NIPT and hereditary cancer NGS panel offerings, though Natera operates globally as a specialty molecular company rather than a regional full-service pathology lab.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Citolab

Clinical Pathology Laboratory Servicescitolab.com.br

Citolab firmographics

Firmographics
Name
Citolab
Legal name
Citolab Laboratório de Citologia Clínica e Histopatologia Ltda
Website
https://citolab.com.br
Company type
Private
Founded year
1989
Operating status
Operating
Headcount range
51–100 employees
Ownership category
akta.pro rank

Citolab industry classification

Industry
Product category
Clinical Pathology Laboratory Services
NAICS
Medical Laboratories (621511)
SIC
Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAFAMAE
Molecular Diagnostics & Genomics Laboratories
SECONDARYHLAGAEAB
Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)

Keywords

  • Clinical pathology services
  • Cytology diagnostics
  • Histopathology testing
  • Immunohistochemistry services
  • Molecular diagnostics

Where Citolab is headquartered

Location

Headquarters

HQ city
Curitiba
HQ country
Brazil
HQ region
Latin America

Offices3 records

Markets served

Citolab business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

  1. Clinical pathology services: Laboratory diagnostic services including cytology, histopathology, immunohistochemistry, and molecular testing for medical clinics, hospitals, and healthcare providers. Services are billed through health insurance plans (convênios) or direct patient payment.
  2. Specialized diagnostic testing: Advanced genetic testing services including NIPT, hereditary cancer panels, nutrigenetic tests (NutriGen), sports genetics (GymGen, FitGen), dermatogenetic testing (AgeGen), and sex determination testing
  3. Healthcare insurance (Convênios): Partnership with health insurance providers for covered diagnostic services

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Citolab product offering

Product offering

Core offering

Citolab is a clinical cytology and histopathology laboratory providing anatomical pathology, biopsy and surgical specimen analysis, cytology (conventional and liquid-based SurePath), automated immunohistochemistry with 48-72 hour turnaround, molecular diagnostics including NGS hereditary cancer panels, HPV genotyping, and specialized pathology services. The lab also offers genetic testing (nutrigenetics, sports genetics, dermatogenetics), prenatal testing (NIPT, fetal sexing), infectious disease panels, and COVID-19 antigen testing for healthcare providers and patients in the Curitiba metropolitan region.

Product overview

Citolab is a clinical cytology and histopathology laboratory offering comprehensive anatomical pathology and diagnostic testing services. The core portfolio centers on anatomical pathology services including surgical specimen analysis, biopsies, cytology (conventional and liquid-based), and intraoperative frozen section examinations. The laboratory provides specialized immunohistochemistry with automated 48-72 hour turnaround and molecular diagnostics including NGS hereditary cancer panels (26 genes), HPV genotyping, and KRAS/NRAS/BRAF testing. Citolab also offers genetic testing services (NutriGen, GymGen, FitGen, AgeGen) for nutrigenetics, athletic performance, fitness optimization, and dermatogenetics. Prenatal testing includes NIPT and fetal sexing via PCR. The service portfolio spans oncology diagnostics, infectious disease testing (STI panels, COVID-19), neuropathology, dermatopathology, and mastopathology, complemented by 24-hour logistics support and digital result delivery. The laboratory operates multiple collection sites in Curitiba and São José dos Pinhais with priority service for transplant patients.

Differentiator

Problem solved

Functional benefit

Products and services

  • Anatomical Pathology / Biopsies / Surgical Specimens
  • Cytopathology (Liquid-Based and Conventional)
  • Immunohistochemistry / Immunocytochemistry
  • Molecular Diagnostics (NGS Hereditary Cancer Panel)
  • HPV Testing and Genotyping
  • NIPT - Non-Invasive Prenatal Test
  • Neuropathology Services
  • Dermatopathology Services
  • Mastopathology Services
  • NutriGen - Nutrigenetic Test
  • GymGen / FitGen - Genetic Sports and Fitness Tests
  • AgeGen - Dermatogenetic Test
  • STI/IST Molecular Panel
  • KRAS/NRAS/BRAF Molecular Studies
  • Microsatellite Instability (MSI) Testing
  • COVID-19 Antigen Rapid Test
  • Per-Operative Frozen Section Examination
  • Fine Needle Aspiration Biopsy (FNAB)
  • Second Opinion / Slide Review
  • 24-Hour Logistics Assistance

Quantifiable outcome

  • Immunohistochemistry turnaround time of 48-72 hours
  • +3 more outcomes

Companies that use Citolab

Customer profile

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Citolab technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature5 records

Citolab partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves8 records

Expansion highlights3 records

Citolab competitors and assessment

Company assessment

Others

  • Genomic Health (Exact Sciences): US-based molecular diagnostics company commercialising Oncotype DX and other genomic oncology tests globally. Not a direct competitor but provides comparable molecular/genomic oncology testing that Brazilian specialty labs like Citolab compete against in hereditary cancer and tumor profiling cases.
  • Hospital Israelita Albert Einstein: Brazilian tertiary hospital system operating an integrated clinical laboratory and reference diagnostic service for complex and esoteric testing. Adjacent rather than directly competing with Citolab, but engages the same specialist pathologists and serves overlapping subspecialty referral cases from across Brazil.

Direct peers

  • Sabin Medicina Diagnóstica: Brazilian diagnostic medicine chain offering clinical analysis, imaging, and specialty testing through a network of patient service centers across multiple states. Closest direct comparable in business model to Citolab: anatomical pathology, molecular diagnostics, convênio partnerships, and physician-referred testing in a Brazilian regional hub context.
  • Laboratório Hermes Pardini: Large Brazilian clinical laboratory with a strong specialty and molecular diagnostics portfolio, including genetic testing and hospital partnerships. Highly comparable to Citolab in test menu breadth (oncology IHC, molecular, genetics) and target customer base (hospitals, clinicians, convênios), though at materially larger national scale.
  • DB Diagnósticos: Brazilian clinical diagnostics chain with regional presence focused on routine and specialty testing for physicians, hospitals, and convênios. Comparable to Citolab in business model (clinical analysis, convênio billing, physician referrals) and regional hub footprint in Brazil.

Broad incumbents

  • Quest Diagnostics: US clinical laboratory incumbent offering anatomical pathology, molecular diagnostics, and genetic testing at nationwide scale through physician and hospital channels. Comparable to Citolab in test categories and physician-referred anatomical pathology, but vastly larger and operating in a different regulatory and reimbursement environment.
  • Dasa (Diagnósticos da América): Largest Brazilian integrated diagnostics company operating brands such as Delboni Auriemo, Sérgio Franco, and Pasteur across clinical analysis, imaging, and hospital diagnostics. Operates in the same anatomical pathology, molecular, and convênio-driven market as Citolab but at national scale across hundreds of units and integrated hospital systems.
  • NeoGenomics: US specialty oncology testing company focused on molecular and anatomic pathology for hospitals, oncologists, and clinical trials. Highly comparable to Citolab in subspecialty oncology and molecular focus, though operating at multi-state US scale rather than regional Brazilian scale.
  • Fleury: Major Brazilian diagnostics company offering clinical analysis, imaging, and specialty testing with a strong reference-lab positioning in oncology and genetics. Comparable to Citolab in subspecialty test offerings and physician-referral channel, but with a São Paulo-centric premium positioning and far larger operating scale.

Emerging players

  • Natera: US-based cell-free DNA testing company with leading NIPT, hereditary cancer, and oncology monitoring products. Direct comparable to Citolab's NIPT and hereditary cancer NGS panel offerings, though Natera operates globally as a specialty molecular company rather than a regional full-service pathology lab.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Citolab social profiles

Digital presence

Citolab financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Citolab leadership team

Management profile

Number of profiles

Profiles6 records

Citolab funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Citolab M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Citolab

What does Citolab do?

Citolab is a clinical cytology and histopathology laboratory providing anatomical pathology, biopsy and surgical specimen analysis, cytology (conventional and liquid-based SurePath), automated immunohistochemistry with 48-72 hour turnaround, molecular diagnostics including NGS hereditary cancer panels, HPV genotyping, and specialized pathology services. The lab also offers genetic testing (nutrigenetics, sports genetics, dermatogenetics), prenatal testing (NIPT, fetal sexing), infectious disease panels, and COVID-19 antigen testing for healthcare providers and patients in the Curitiba metropolitan region.

Is Citolab a public or private company?

Citolab is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Citolab founded?

Citolab was founded in 1989. It employs 51 to 100 people.

Where is Citolab based?

Citolab is headquartered in Curitiba, Brazil, in the Latin America region.

How does Citolab make money?

Three revenue lines are on record. Clinical pathology services are the primary driver. The others are specialized diagnostic testing and healthcare insurance (Convênios).

Who are Citolab's main competitors?

Others on record are Genomic Health (Exact Sciences) and Hospital Israelita Albert Einstein. Direct peers are Sabin Medicina Diagnóstica, Laboratório Hermes Pardini and DB Diagnósticos. Broad incumbents are Quest Diagnostics, Dasa (Diagnósticos da América), NeoGenomics and Fleury. Natera is listed as an emerging player.

Does Citolab have an API?

No public API is recorded for Citolab.

What industry is Citolab in?

Citolab's product category is Clinical Pathology Laboratory Services. Its primary akta.pro industry code is HLAFAMAE, Molecular Diagnostics & Genomics Laboratories, with a secondary code of HLAGAEAB, Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales